Aurolife Pharma, LLC

Form 483

Dayton, New Jersey, United StatesFEI 3005796917Issued May 25, 2011

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3005796917.

Observations3

Issue DateMay 25, 2011

Status1 Related Warning Letter

Related Inspections10

Establishment Details

Firm: Aurolife Pharma, LLC
Location: Dayton, New Jersey, United States
FEI Number: 3005796917
Product Type: Drugs
Issue Date: May 25, 2011
Country: United States

Inspection History, 2009 to 2021

NAI4

VAI5

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Aurolife Pharma, LLC FDA Form 483, Dayton, New Jersey, May 25, 2011